mTOR Inhibition and Tuberous Sclerosis Prevention

Abstract

Investigators at Children's Memorial Health Institute, Warsaw, Poland, report monozygotic twin sisters with tuberous sclerosis complex (TSC), one treated with the mTOR inhibitor everolimus since age 4 years.

Keywords

• tuberous sclerosis complex
• angiomyolipomas
• facial angiofibroma